You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our B-Cell CLL/lymphoma 9-Like (BCL9L) ELISA Kits

Full name:
B-Cell CLL/lymphoma 9-Like ELISA Kits (BCL9L)
On are 2 B-Cell CLL/lymphoma 9-Like (BCL9L) ELISA Kits from 2 different suppliers available. Additionally we are shipping B-Cell CLL/lymphoma 9-Like Antibodies (35) and B-Cell CLL/lymphoma 9-Like Proteins (3) and many more products for this protein. A total of 50 B-Cell CLL/lymphoma 9-Like products are currently listed.
2610202E01Rik, 8030475K17Rik, A330041G23Rik, B9L, BC003321, bcl9-2, BCL9L, DLNB11, Gm130, LGS
list all ELISA KIts Gene Name GeneID UniProt
Mouse BCL9L BCL9L 77578 Q9D219
BCL9L 607 O00512
Rat BCL9L BCL9L 300673  

Show all species

Show all synonyms

B-Cell CLL/lymphoma 9-Like (BCL9L) ELISA Kits by Reactivity

Select your species

More ELISA Kits for B-Cell CLL/lymphoma 9-Like Interaction Partners

Mouse (Murine) B-Cell CLL/lymphoma 9-Like (BCL9L) interaction partners

  1. Study demonstrates that the Golgi resident protein GM130 (show GOLGA2 ELISA Kits) activates the spindle assembly factor TPX2 (show DAZL ELISA Kits) to nucleate microtubules around the Golgi and further captures them to couple mitotic membranes to the spindle.

  2. BCL9-2 induces ER positive breast cancers in vivo, regulates ER expression by a novel ss-catenin independent mechanism in breast cancer cells.

  3. Pax6 (show PAX6 ELISA Kits), the master regulator of eye development, directly activates Bcl9 (show BCL9 ELISA Kits)/9l transcription.

  4. Data show that the GCM1/syncytin-B pathway is significantly downregulated in the placenta of BCL9L-deficient mice and that the fusion and differentiation of ST-II cells are blocked.

  5. BCL9-2 promotes early phases of intestinal tumor progression in humans and in transgenic mice. BCL9-2 increases the expression of a subset of canonical Wnt (show WNT2 ELISA Kits) target genes but also regulates genes that are required for early stages of tumor progression.

  6. These results suggest a critical role of BCL9 (show BCL9 ELISA Kits)/9-2 in the Wnt (show WNT2 ELISA Kits)-mediated regulation of adult, as opposed to embryonic, myogenic progenitors.

  7. We demonstrated that nuclear B9L expression was closely associated with the high nuclear grade cancer phenotype and the expression of ErbB2/HER-2 (show ERBB2 ELISA Kits) in breast cancers.

Human B-Cell CLL/lymphoma 9-Like (BCL9L) interaction partners

  1. it was demonstrated that miR218 modulated a novel molecular target and the present study provided novel insights into potential mechanisms of RCC (show XRCC1 ELISA Kits) oncogenesis.

  2. findings indicate that BCL9 (show BCL9 ELISA Kits) most likely does not harbor a common genetic variant that can increase the risk for schizophrenia in the Japanese population

  3. BCL9 (show BCL9 ELISA Kits)/9L-beta-catenin (show CTNNB1 ELISA Kits) Signaling is Associated With Poor Outcome in Colorectal Cancer

  4. BCL9 (show BCL9 ELISA Kits) is a molecular driver of DCIS invasive progression.

  5. PCDH10 (show PCDH10 ELISA Kits) antagonized MM cell proliferation via the downregulation of Wnt (show WNT2 ELISA Kits)/beta-catenin (show CTNNB1 ELISA Kits)/BCL-9 (show BCL9 ELISA Kits) signaling, whereas PCDH10 (show PCDH10 ELISA Kits) repressed the expression of AKT (show AKT1 ELISA Kits) to promote the expression of GSK3beta and then to restrain the activation of beta-catenin (show CTNNB1 ELISA Kits)

  6. The inhibition of the transcriptional activity of BCL9-2 by WWOX (show WWOX ELISA Kits) and HDAC3 (show HDAC3 ELISA Kits) constitutes a new molecular mechanism and provides new insight for a broad range of cancers.

  7. BCL9-2 induces ER positive breast cancers in vivo, regulates ER expression by a novel ss-catenin independent mechanism in breast cancer cells.

  8. By beta-catenin's association with LEF1 (show LEF1 ELISA Kits) and BCL9-2/B9L.

  9. MiR (show MLXIP ELISA Kits)-30-5p downregulation occurs as a result of interaction between multiple myeloma cells and bone marrow stromal cells, which in turn enhances expression of BCL9 (show BCL9 ELISA Kits).

  10. we detected five SNPs in the first two genes/loci - BCL9 and C9orf5 - strongly associated with negative symptoms of schizophrenia

B-Cell CLL/lymphoma 9-Like (BCL9L) Antigen Profile

Antigen Summary

BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.

Alternative names and synonyms associated with B-Cell CLL/lymphoma 9-Like (BCL9L)

  • B-cell CLL/lymphoma 9-like (BCL9L) Elisa Kit
  • B cell CLL/lymphoma 9 (Bcl9) Elisa Kit
  • B cell CLL/lymphoma 9-like (Bcl9l) Elisa Kit
  • B-cell CLL/lymphoma 9 (BCL9) Elisa Kit
  • B-cell CLL/lymphoma 9-like (Bcl9l) Elisa Kit
  • B-cell CLL/lymphoma 9-like (bcl9l) Elisa Kit
  • 2610202E01Rik Elisa Kit
  • 8030475K17Rik Elisa Kit
  • A330041G23Rik Elisa Kit
  • B9L Elisa Kit
  • BC003321 Elisa Kit
  • bcl9-2 Elisa Kit
  • BCL9L Elisa Kit
  • DLNB11 Elisa Kit
  • Gm130 Elisa Kit
  • LGS Elisa Kit

Protein level used designations for BCL9L

B-cell CLL/lymphoma 9-like , b-cell CLL/lymphoma 9-like protein-like , B-cell CLL/lymphoma 9 protein , B-cell lymphoma 9 protein , bcl-9 , nuclear co-factor of beta-catenin signalling , B-cell CLL/lymphoma 9-like protein , B-cell lymphoma 9-like protein , BCL9-like protein , BCL9-related beta-catenin-binding protein , protein BCL9-2 , protein legless homolog

419785 Gallus gallus
451596 Pan troglodytes
489377 Canis lupus familiaris
539340 Bos taurus
100063146 Equus caballus
100444640 Pongo abelii
100515846 Sus scrofa
77578 Mus musculus
80288 Mus musculus
607 Homo sapiens
100155378 Sus scrofa
283149 Homo sapiens
300673 Rattus norvegicus
449532 Danio rerio
Selected quality suppliers for B-Cell CLL/lymphoma 9-Like (BCL9L) ELISA Kits
Did you look for something else?